It is known that MCs from patients with a non-advanced CMCD exhibit an aberrant active phenotype with lower surface expression of CD117 and overexpression of the activation markers CD203c and CD63 (33, 34). This evidence concerns the gene KIT and cutaneous mastocytosis.